Experts
Supporters
About Mirrors of Medicine
Disease Area
Bladder cancer
Breast cancer
Chronic pain
COVID-19
Lower Urinary Tract Dysfunction
Prostate cancer
Prostate cancer (US version)
Renal Cell Carcinoma
Method
Accreditation
my dashboard
Join
Login
EN
EN
FR
DE
IT
ES
RU
UK
Bladder cancer
Breast cancer
Chronic pain
COVID-19
Lower Urinary Tract Dysfunction
Prostate cancer
Prostate cancer (US version)
Renal Cell Carcinoma
Method
Accreditation
Method
Experts
Supporters
Principles
About Mirrors of Medicine
Contact
Bladder cancer
Follow-up surveillance regimes to consider for (very) high-risk NMIBC and MIBC
Editor in chief
Experts & associates
Background & relevance
Last update: 22-11-2022
View the PinPoint cases (
) and get feedback
High-risk NMIBC treated with BCG
Very high-risk NMIBC treated with RC (orthotopic neobladder)
MIBC treated with TMT (evaluation of response)
Very high-risk NMIBC treated with BCG
Very high-risk NMIBC treated with RC (ileal conduct)
MIBC treated with TMT (surveillance regimes)
MIBC treated with RC (orthotopic neobladder)
MIBC treated with TMT (duration of surveillance)